Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Order: Signal: Tickers:
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Quotes Basic TA News Snapshot
Total: 130 #1
TickerDRIV [NASD]
CompanyDigital River Inc.
CountryUSA
IndustryInternet Software & Services
Market Cap820.29MEPS (ttm)-0.67
P/E-EPS this Y89.50%
Forward P/E45.24EPS next Y24.89%
PEG-EPS past 5Y-18.90%
P/S2.20EPS next 5Y10.00%
P/B2.14EPS Q/Q-
Dividend-Sales Q/Q-3.10%
Insider Own1.50%Inst Own83.90%
Insider Trans16.80%Inst Trans-0.19%
Short Float3.41%EarningsOct 29/a
Analyst Recom3.10Target Price18.57
Avg Volume231.48K52W Range13.61 - 19.67
24-Oct-14 08:00PMHarwood Feffer LLP Announces Investigation of Digital River, Inc. PR Newswire
24-Oct-14 05:23PMStock Pops & Drops: GoPro gets hit CNBC
24-Oct-14 02:59PMWell-timed bullish option bets seen in Digital River weeks before deal Reuters
24-Oct-14 02:36PMDigital River, Inc. Stockholders Encouraged to Contact Securities Law Firm about Takeover PR Newswire
24-Oct-14 01:15PMDIGITAL RIVER, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout Business Wire
24-Oct-14 01:14PMEQUITY ALERT: Rosen Law Firm Announces Investigation of Digital River, Inc. Concerning Its Proposed Sale to Investor Group Led by Siris Capital Group Business Wire
24-Oct-14 12:55PMPandora Plunges on News of Slowed Growth at TheStreet
24-Oct-14 12:19PMDIGITAL RIVER SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Going Private Proposal Business Wire
24-Oct-14 12:16PMDIGITAL RIVER, INC. INVESTOR ALERT: Levi & Korsinsky, LLP Investigates the Board of Directors of Digital River, Inc. Regarding the Fairness of the Sale of the Company to Siris Capital Group, LLC Business Wire
24-Oct-14 11:41AMDigital River Agrees To Private Equity Sale at Investor's Business Daily
Digital River, Inc. provides end-to-end cloud-commerce, payments, and marketing solutions to various companies in the United States, Europe, the Asia Pacific, and South America. Its solution combines a Commerce-as-a-Service commerce technology platform, commerce business infrastructure (CBI), and a suite of services to help businesses to avoid the costs and risks of running an integrated global commerce operation in-house. The company offers various services, including design, development, and hosting of commerce stores; merchandising; order management; fraud prevention screening; processing of popular localized online payment methods; export controls and management; tax compliance and management; digital product delivery via download; physical product fulfillment; multi-lingual customer service; subscription management; online marketing services, such as email marketing; paid search program management; Website optimization; and Web analytics and reporting services, as well as other programs. It also offers payment provider services, including payment gateway services, merchant set-up and training, transaction authorization and electronic draft capture, clearing and settlement, merchant accounting, merchant assistance and support and risk management, and electronic payment processing services. In addition, the company provides paid search advertising, search engine optimization and marketing, affiliate marketing, display advertising, store optimization, and email marketing and optimization services. It serves digital products and cloud services companies; consumer electronics, electronic toys, housewares, medical equipment, power tools, and sporting equipment manufacturers; and channel partners, including retailers and affiliates. The company sells its products and services to consumers through the Internet, as well as through direct sales force. Digital River, Inc. was founded in 1994 and is headquartered in Eden Prairie, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cahall Theodore R JrEVP & COOFeb 18Buy17.1858510,05085,235Feb 20 04:03 PM
VEPF III AIV V, L.P.10% OwnerOct 31Sale18.00260,0004,680,0003,236,941Nov 04 08:24 PM
TickerRGLS [NASD]
CompanyRegulus Therapeutics Inc.
CountryUSA
IndustryBiotechnology
Market Cap751.95MEPS (ttm)-0.67
P/E-EPS this Y76.90%
Forward P/E-EPS next Y27.70%
PEG-EPS past 5Y0.00%
P/S54.10EPS next 5Y-
P/B9.17EPS Q/Q-40.00%
Dividend-Sales Q/Q-85.40%
Insider Own0.20%Inst Own33.10%
Insider Trans-70.86%Inst Trans-0.02%
Short Float11.86%EarningsNov 11/a
Analyst Recom1.70Target Price16.40
Avg Volume596.41K52W Range5.40 - 15.74
23-Oct-14 03:39PM3 Momentum Stocks to Watch in Biotechnology for Continued Upside at TheStreet
23-Oct-14 10:49AMCan The Uptrend Continue for Regulus Therapeutics (RGLS)? Zacks
23-Oct-14 06:30AMStrength Seen in Regulus (RGLS): Stock Soars 103.1% Zacks
22-Oct-14 04:28PMAs earnings season heats up, stocks close on the lows Yahoo Finance Blogs
22-Oct-14 01:50PMRegulus surges on early hepatitis C drug data AP
22-Oct-14 11:52AMRegulus Gets Seat at Hep C Table With Today's Impressive Drug Results at TheStreet
22-Oct-14 10:39AMRegulus Therapeutics Soars 90% On Hepatitis C Treatment News Benzinga
22-Oct-14 08:48AMREGULUS THERAPEUTICS INC. Files SEC form 8-K, Termination of a Material Definitive Agreement EDGAR Online
22-Oct-14 08:30AMRegulus Therapeutics Inc. RG-101 Human Proof of Concept Call scheduled for 8:30 am ET today CCBN
22-Oct-14 07:32AM7:32 am Regulus Therapeutics announced that it has demonstrated human proof-of-concept with a microRNA therapeutic from an ongoing clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated anti-miR targeting microRNA-122, for the Briefing.com
Regulus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery and development of drugs that target microRNAs for the treatment of various diseases in the United States. The company uses its microRNA product platform to develop anti-miRs, which is chemically modified and single-stranded oligonucleotide. Its clinical candidate products include RG-101, which is a GalNAc-conjugated anti-miR that targets microRNA-122 for the treatment of patients with chronic hepatitis C virus infection. The company has strategic collaboration with Biogen Idec MA Inc. for the evaluation of the use of microRNA signatures as a biomarker for human patients with multiple sclerosis; AstraZeneca AB to discover and develop microRNA therapeutics for cardiovascular diseases, metabolic diseases, and oncology; and GlaxoSmithKline plc to discover and develop microRNA therapeutics for immuno-inflammatory diseases. It also has strategic collaboration with Sanofi for the discovery and development of microRNA therapeutics comprising miR-21 pre-clinical fibrosis program for the treatment of alport syndrome and preclinical program for oncology indications; and preclinical programs targeting miR-221/222 for oncology indications. Regulus Therapeutics Inc. was founded in 2007 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gibson Neil WChief Scientific OfficerOct 22Option Exercise1.743,3005,74283,300Oct 24 04:16 PM
Gibson Neil WChief Scientific OfficerOct 22Sale14.443,30047,64480,000Oct 24 04:16 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOOct 20Option Exercise0.383001142,766Oct 21 04:07 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOOct 20Sale7.003002,1002,466Oct 21 04:07 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOOct 17Option Exercise0.384001522,866Oct 21 04:07 PM
TickerBJRI [NASD]
CompanyBJ's Restaurants, Inc.
CountryUSA
IndustryRestaurants
Market Cap1.19BEPS (ttm)0.58
P/E72.67EPS this Y-33.00%
Forward P/E42.11EPS next Y29.33%
PEG3.59EPS past 5Y13.40%
P/S1.46EPS next 5Y20.22%
P/B2.92EPS Q/Q-6.70%
Dividend-Sales Q/Q10.50%
Insider Own0.20%Inst Own84.50%
Insider Trans-0.15%Inst Trans0.82%
Short Float10.65%EarningsOct 23/a
Analyst Recom2.70Target Price33.15
Avg Volume316.49K52W Range25.11 - 38.20
24-Oct-14Reiterated Wunderlich Buy $36 → $42
24-Oct-14 03:23PMMid-Afternoon Market Update: Microsoft Rises After Strong Results; DryShips Shares Decline Benzinga
24-Oct-14 12:41PMMid-Day Market Update: Amazon Drops On Downbeat Results; Digital River Shares Spike Higher Benzinga
24-Oct-14 11:06AMMid-Morning Market Update: Markets Flat; Ford Posts Upbeat Profit Benzinga
24-Oct-14 10:15AMBJ's Restaurants (BJRI) Beats Q3 Earnings, Shares Up 11.5% Zacks
24-Oct-14 07:07AMBJ's Restaurants (BJRI) in Focus: Stock Falls 5.8% Zacks
23-Oct-14 04:54PMBJ's Restaurants beats 3Q profit forecasts AP
23-Oct-14 04:41PMWhy BJs Restaurants (BJRI) Stock Is Soaring in After-Hours Trading Today at TheStreet
23-Oct-14 04:18PM4:18 pm BJ Restaurants beats by $0.10, reports revs in-line; comps +0.3% Briefing.com
23-Oct-14 04:04PMBJS RESTAURANTS INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Princip EDGAR Online
23-Oct-14 04:03PMBJ's Restaurants, Inc. Reports Fiscal Third Quarter Results GlobeNewswire
BJ's Restaurants, Inc. owns and operates casual dining restaurants in the Unites States. The company's restaurants offer pizzas, beers, appetizers, entrees, pastas, sandwiches, salads, and desserts. As of October 7, 2014, it owned and operated 154 casual dining restaurants under the BJ's Restaurant & Brewery, BJ's Restaurant & Brewhouse, BJ's Pizza & Grill, and BJ's Grill brands. The company was founded in 1978 and is based in Huntington Beach, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Krakower Brian SChief Information OfficerAug 29Option Exercise30.572,83586,6662,835Aug 29 04:50 PM
Krakower Brian SChief Information OfficerAug 29Sale37.122,835105,2350Aug 29 04:50 PM
Jones Wayne L.Exec VP,Chief Rest. Ops OfcerAug 27Option Exercise11.6810,000116,8005,000Aug 28 04:56 PM
Jones Wayne L.Exec VP,Chief Rest. Ops OfcerAug 27Sale37.7510,000377,5000Aug 28 04:56 PM
BASSI PETER ADirectorAug 26Option Exercise14.945,15577,01645,155Aug 26 08:13 PM
TickerHVB [NYSE]
CompanyHudson Valley Holding Corp.
CountryUSA
IndustryRegional - Northeast Banks
Market Cap459.97MEPS (ttm)-0.10
P/E-EPS this Y-96.00%
Forward P/E27.99EPS next Y24.36%
PEG-EPS past 5Y-50.70%
P/S5.08EPS next 5Y5.00%
P/B1.55EPS Q/Q-33.30%
Dividend1.39%Sales Q/Q3.60%
Insider Own1.70%Inst Own42.70%
Insider Trans2.10%Inst Trans0.19%
Short Float3.78%EarningsOct 27/a
Analyst Recom2.80Target Price19.67
Avg Volume29.00K52W Range16.53 - 21.12
24-Oct-14 04:53PMHudson Valley Bank Said to Explore Sale Advised by KBW at Bloomberg
10-Oct-14 05:14PMHUDSON VALLEY HOLDING CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Ex EDGAR Online
08-Oct-14 05:10PMHudson Valley Holding Corp. To Announce 2014 Third Quarter Results And Host A Conference Call PR Newswire
18-Aug-14 04:01PMHudson Valley Holding Corp. To Present At 2014 Raymond James U.S. Bank Conference PR Newswire
15-Aug-14 01:04PMHUDSON VALLEY HOLDING CORP Financials EDGAR Online Financials
08-Aug-14 11:19AMHudson Valley Bank Provides Funding PR Newswire
06-Aug-14 01:18PMHUDSON VALLEY HOLDING CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
25-Jul-14 05:20PMHUDSON VALLEY HOLDING CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
25-Jul-14 04:05PMHudson Valley Holding Corp. Announces Financial Results For The Second Quarter Of 2014 PR Newswire
25-Jul-14 07:07AMQ2 2014 Hudson Valley Holding Corp Earnings Release - After Market Close CCBN
Hudson Valley Holding Corp. operates as the bank holding company for Hudson Valley Bank, N.A. that provides banking and related services to businesses, professionals, municipalities, not-for-profit organizations, and individuals in New York. The company offers various deposit products, including non-interest bearing demand deposit, checking with interest, money market, and savings accounts, as well as various forms of time deposits. It also provides a range of loans that comprise commercial real estate loans; construction loans secured by land for residential and commercial development; residential real estate loans, including 1-4 family residential mortgages, multi-family residential loans, and home equity line of credit products; commercial business loans, and lines of credit; installment loans and reserve lines of credit; and lease financing principally for office equipment, telephone systems, computer systems, energy saving improvements, and other special use equipment. In addition, the company offers investment management and broker-dealer services. Further, it provides a software application to meet the specific administrative needs of bankruptcy trustees through a marketing and licensing agreement with the application vendor. As of April 2, 2014, it operated 28 branches. Hudson Valley Holding Corp. was founded in 1972 and is headquartered in Yonkers, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
THOMPSON CRAIG SDirectorJun 05Sale17.831,00017,826153,254Jun 06 10:19 AM
Finn Michael EEVP of Primary Operating SubJun 03Buy17.381,92533,4666,500Jun 04 12:20 PM
Finn Michael EEVP of Primary Operating SubJun 02Buy17.5557510,0914,575Jun 04 12:20 PM
Indiveri Michael J.Executive Vice President & CFOMay 22Buy17.1670012,0156,125May 27 12:02 PM
Blose James PEVP, General CounselMay 15Buy17.345008,670500May 15 04:56 PM
TickerSTRT [NASD]
CompanySTRATTEC Security Corporation
CountryUSA
IndustryAuto Parts
Market Cap345.18MEPS (ttm)4.56
P/E21.20EPS this Y68.80%
Forward P/E18.07EPS next Y5.11%
PEG1.41EPS past 5Y34.90%
P/S0.99EPS next 5Y15.00%
P/B2.68EPS Q/Q-41.90%
Dividend0.50%Sales Q/Q-65.80%
Insider Own2.80%Inst Own83.50%
Insider Trans-2.91%Inst Trans0.03%
Short Float3.95%EarningsOct 23
Analyst Recom2.00Target Price82.50
Avg Volume23.30K52W Range36.97 - 89.74
24-Oct-14 03:00PMDelphi Asia & North America Sales Drive Q3 Earnings Beat Zacks
24-Oct-14 05:03AMStrattec Security posts 1Q profit AP
23-Oct-14 05:08PMSTRATTEC SECURITY CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex EDGAR Online
23-Oct-14 05:00PMSTRATTEC SECURITY CORPORATION Reports Record Fiscal 2015 First Quarter Sales and Operating Results GlobeNewswire
23-Oct-14 07:07AMQ1 2015 Strattec Security Corp Earnings Release - Tentative - Time Not Supplied CCBN
21-Oct-14 08:50AMHarley-Davidson's Q3 Earnings Fall on Lower Shipments Zacks
16-Oct-14 04:00PMSTRATTEC SECURITY CORPORATION Named 2014 Supplier of the Year by Ford Rotunda GlobeNewswire
07-Oct-14 04:22PMSTRATTEC SECURITY CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Regulation FD Disclos EDGAR Online
07-Oct-14 04:00PMSTRATTEC SECURITY CORPORATION Declares Quarterly Dividend GlobeNewswire
30-Sep-14 04:54PMSTRATTEC SECURITY CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
STRATTEC SECURITY CORPORATION designs, develops, manufactures, and markets automotive access control products. Its products include mechanical locks and keys, electronically enhanced locks and keys, steering column and instrument panel ignition lock housings, power sliding door systems, power lift gate systems, power deck lid systems, door handles, and related products. The company also provides full service and aftermarket support services to its products. STRATTEC SECURITY CORPORATION offers its products under the VAST brand name. It operates in the United States, Canada, Mexico, Europe, South America, Korea, and China. The company offers its products directly, as well as through wholesale distributors, and other marketers and users. STRATTEC SECURITY CORPORATION is headquartered in Milwaukee, Wisconsin.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HANSEN PATRICK JSenior VP and CFOAug 29Sale78.0620015,6128,500Sep 02 04:44 PM
STRATTON HAROLD M IIDirectorAug 29Sale78.495,000392,45044,964Sep 02 04:31 PM
HANSEN PATRICK JSenior VP and CFOAug 26Sale75.42947,0898,700Aug 26 04:27 PM
HANSEN PATRICK JSenior VP and CFOAug 25Sale75.9580661,2168,794Aug 26 04:27 PM
Messina Richard PVP - Global Sales/Access CntrlAug 25Sale74.9980059,9925,000Aug 26 04:45 PM
TickerEW [NYSE, S&P 500]
CompanyEdwards Lifesciences Corp.
CountryUSA
IndustryMedical Appliances & Equipment
Market Cap12.38BEPS (ttm)7.01
P/E16.66EPS this Y38.70%
Forward P/E30.48EPS next Y15.95%
PEG1.20EPS past 5Y25.60%
P/S5.81EPS next 5Y13.90%
P/B6.44EPS Q/Q528.40%
Dividend-Sales Q/Q11.20%
Insider Own0.80%Inst Own87.70%
Insider Trans2.17%Inst Trans-4.38%
Short Float1.97%EarningsOct 23/a
Analyst Recom2.00Target Price103.22
Avg Volume1.00M52W Range60.62 - 108.73
24-Oct-14Reiterated Northland Capital Outperform $100 → $130
24-Oct-14Reiterated Stifel Buy $100 → $132
24-Oct-14 03:35PMFriday's market movers: EW, PG & more CNBC
24-Oct-14 02:50PMStocks Hold Near Session Highs; Drugmakers Shine Again at Investor's Business Daily
24-Oct-14 12:29PMEdwards Lifesciences Hits New High On Q3 Earnings at Investor's Business Daily
24-Oct-14 11:54AMEdwards Lifesciences (EW) Stock Is Up Double Digits Today After Raising Full Year Forecast at TheStreet
24-Oct-14 11:10AMEdwards Lifesciences Tops Q3 Earnings, Revenues; Ups View Zacks
24-Oct-14 06:38AMRTI Surgical (RTIX) Jumps: Stock Moves 12.6% Higher Zacks
23-Oct-14 07:01PMEdwards ups '14 EPS outlook Investor's Business Daily
23-Oct-14 07:00PMCramer: This stock is cheap CNBC
23-Oct-14 05:00PMEdwards Lifesciences Corp Earnings Call scheduled for 5:00 pm ET today CCBN
23-Oct-14 04:39PMEdwards Lifesciences beats Street 3Q forecasts AP
Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company offers surgical heart valve therapy products, such as tissue heart valves and repair products, which are used to replace or repair a patient's diseased or defective heart valve; and produces pericardial valves from biologically inert animal tissue. Its surgical heart valve therapy products include Carpentier-Edwards PERIMOUNT pericardial valve that comprise PERIMOUNT Magna Ease valves for aortic and mitral replacement; ThruPort systems that enable minimal incision valve surgery; and protection cannulae that is used during cardiac surgery in venous drainage, aortic perfusion, venting, and cardioplegia delivery. The company also provides transcatheter heart valves portfolio that includes technologies designed to treat heart valve disease using catheter-based approaches, as well as critical care products, such as hemodynamic monitoring systems to measure a patient's heart function in surgical and intensive care settings; Swan-Ganz line of pulmonary artery and PreSep continuous venous oximetry catheters for measuring central venous oxygen saturation; VolumeView sensor-catheters; FloTrac continuous cardiac output monitoring system, a minimally invasive cardiac monitoring technology for fluid optimization; and EV1000 clinical monitoring platform, which displays a patient's physiologic status. Its critical care products also include disposable pressure monitoring devices and closed blood sampling systems to help protect patients and clinicians from the risk of infection; and peripheral vascular products used to treat endolumenal occlusive disease, such as balloon-tipped, catheter-based embolectomy products, surgical clips, and clamps. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WANG HUIMINCVP, Japan & IntercontinentalOct 06Option Exercise27.775,600155,51237,309Oct 07 05:03 PM
WANG HUIMINCVP, Japan & IntercontinentalOct 06Sale107.005,600599,20031,709Oct 07 05:03 PM
BOBO DONALD E JRCVP, Heart Valve TherapyOct 03Option Exercise31.4725,000786,75045,721Oct 03 07:03 PM
BOBO DONALD E JRCVP, Heart Valve TherapyOct 03Sale105.0025,0002,625,00020,721Oct 03 07:03 PM
MUSSALLEM MICHAEL AChairman & CEOSep 29Option Exercise27.7729,500819,215293,350Sep 29 05:36 PM
TickerINFU [AMEX]
CompanyInfuSystem Holdings, Inc.
CountryUSA
IndustryMedical Instruments & Supplies
Market Cap89.34MEPS (ttm)0.13
P/E30.69EPS this Y214.30%
Forward P/E12.47EPS next Y68.42%
PEG1.53EPS past 5Y-31.50%
P/S1.34EPS next 5Y20.00%
P/B2.00EPS Q/Q743.80%
Dividend-Sales Q/Q11.60%
Insider Own2.00%Inst Own60.00%
Insider Trans16.07%Inst Trans-0.10%
Short Float1.74%EarningsMay 05/b
Analyst Recom1.00Target Price6.00
Avg Volume91.67K52W Range1.45 - 3.74
08-Aug-14 01:04PMINFUSYSTEM HOLDINGS, INC Financials EDGAR Online Financials
01-Aug-14 06:07AMINFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online
01-Aug-14 06:00AMInfuSystem Holdings, Inc. Reports Second Quarter Revenue of $16.4 Million and Net Profit of $0.04 Per Share Business Wire
10-Jul-14 10:48AMINFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online
09-Jul-14 02:55PMInfuSystem Holdings, Inc. to Issue Second Quarter 2014 Financial Results on Friday, August 1, 2014 Marketwired
09-Jul-14 10:43AMINFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
28-May-14 04:13PMINFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exh EDGAR Online
20-May-14 09:33AMINFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Stat EDGAR Online
16-May-14 05:14PMINFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
12-May-14 03:58PMINFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related services in the United States and Canada. The company supplies electronic ambulatory infusion pumps and associated disposable kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer. It also sells, rents, and leases new and pre-owned pole mounted and ambulatory infusion pumps to oncology practices; and provides biomedical certification, maintenance, and repair services for oncology practices, as well as to other alternate site settings, including home care and home infusion providers, skilled nursing facilities, pain centers, and others. In addition, the company sells various primary and secondary tubing, cassettes, catheters, and other disposable items that are utilized with infusion pumps. Further, it offers pump management services for the pumps and associated disposable supply kits to approximately 1,800 oncology clinics. The company delivers local and field-based customer support, as well as operates pump service and repair centers. As of December 31, 2013, it owned a fleet of approximately 20,000 new and used pole mounted and ambulatory pumps. The company was founded in 2005 and is headquartered in Madison Heights, Michigan.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Steen Eric KChief Executive OfficerAug 27Buy2.7515,00041,25071,184Aug 27 03:53 PM
Steen Eric KChief Executive OfficerAug 18Buy2.7912,75035,57356,184Aug 19 04:05 PM
Steen Eric KChief Executive OfficerAug 13Buy2.797,25020,22843,434Aug 14 03:15 PM
Steen Eric KChief Executive OfficerAug 11Buy2.77123336,184Aug 14 03:15 PM
Steen Eric KChief Executive OfficerAug 11Buy2.715001,35536,172Aug 12 03:33 PM
TickerWOOF [NASD]
CompanyVCA Inc.
CountryUSA
IndustryPersonal Services
Market Cap3.87BEPS (ttm)1.62
P/E27.69EPS this Y200.00%
Forward P/E21.40EPS next Y12.87%
PEG2.08EPS past 5Y-0.30%
P/S2.10EPS next 5Y13.33%
P/B2.93EPS Q/Q10.90%
Dividend-Sales Q/Q5.20%
Insider Own0.80%Inst Own95.00%
Insider Trans-19.02%Inst Trans-2.44%
Short Float3.74%EarningsOct 23/a
Analyst Recom2.50Target Price43.50
Avg Volume828.93K52W Range26.84 - 42.14
24-Oct-14 01:23PMVCA Inc. to Present at Stephens Fall Investment Conference Business Wire
23-Oct-14 06:18PMVCA beats Street 3Q forecasts AP
23-Oct-14 04:30PMVCA Inc Earnings Call scheduled for 4:30 pm ET today CCBN
23-Oct-14 04:02PM4:02 pm VCA Antech beats by $0.04, reports revs in-line; guides Q4 EPS in-line Briefing.com
23-Oct-14 04:01PMVCA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
23-Oct-14 04:00PMVCA Inc. Reports Third Quarter 2014 Results Business Wire
23-Oct-14 08:55AMCannabis Therapy Gears Up Canna-Pet Business Accesswire
23-Oct-14 07:07AMQ3 2014 VCA Inc Earnings Release - 4:00 pm ET CCBN
21-Oct-14 12:58PMLarry Robbins has four big stock ideas at CNBC
21-Oct-14 11:27AM[video] Glenviews Larry Robbins Bets on Millennials Growing Up at Bloomberg
VCA Inc. operates as an animal healthcare company in the United States and Canada. It operates through two segments, Animal Hospital and Laboratory. The Animal Hospital segment offers general medical and surgical services, as well as specialized treatments comprising advanced diagnostic services, internal medicine, oncology, neurology, endocrinology, ophthalmology, dermatology, and cardiology for companion animals; and sells related retail and pharmaceutical products. This segment also provides specialty pet products, including pet food, vitamins, therapeutic shampoos and conditioners, flea collars and sprays, and other accessory products; and additional services, such as grooming, bathing, and boarding services. The Laboratory segment offers testing and consulting services in the areas of chemistry, pathology, endocrinology, serology, hematology, and microbiology, as well as conducts tests specific to particular diseases. This segment serves animal hospitals, animal practices, universities, and other government organizations. The company also sells digital radiography and ultrasound imaging equipment, related computer hardware, software, and ancillary services to the veterinary market; provides online and printed communications, professional education, and marketing solutions to the veterinary community; and offers an e-commerce platform for independent animal hospitals, as well as provides consulting and mobile imaging services. As of December 31, 2013, it operated 609 animal hospitals and 56 veterinary diagnostic laboratories. The company also provides its services to veterinary practices, pharmaceutical manufacturers, and the pet owning community. The company was formerly known as VCA Antech, Inc. and changed its name to VCA Inc. in June 2014. VCA Inc. was founded in 1986 and is headquartered in Los Angeles, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Drake JoshPresident, Antech DiagnosticsSep 04Option Exercise18.948,584162,58163,855Sep 08 04:33 PM
Drake JoshPresident, Antech DiagnosticsSep 04Sale40.1817,778714,35646,077Sep 08 04:33 PM
Drake JoshPresident, Antech DiagnosticsMar 14Sale33.872,19974,48765,277Mar 18 04:05 PM
Drake JoshPresident, Antech DiagnosticsNov 25Option Exercise18.948,585162,60052,932Nov 26 04:00 PM
REDDICK FRANKDirectorNov 25Option Exercise15.3310,000153,30029,784Nov 26 04:03 PM
TickerROX [AMEX]
CompanyCastle Brands Inc.
CountryUSA
IndustryBeverages - Wineries & Distillers
Market Cap286.86MEPS (ttm)-0.08
P/E-EPS this Y-33.30%
Forward P/E-EPS next Y0.00%
PEG-EPS past 5Y34.80%
P/S5.77EPS next 5Y-
P/B15.42EPS Q/Q0.00%
Dividend-Sales Q/Q15.40%
Insider Own2.50%Inst Own2.00%
Insider Trans-0.64%Inst Trans8.77%
Short Float1.47%EarningsNov 18
Analyst Recom1.00Target Price1.50
Avg Volume731.10K52W Range0.71 - 1.77
23-Oct-14 10:00AMBlue Water Brand Could Capture Premium Rum Market Share Accesswire
23-Oct-14 07:33AMCastle Brands (ROX) in Focus: Stock Moves 6.3% Higher Zacks
20-Oct-14 06:43AMCastle Brands (ROX) Looks Strong as Stock Surges 14.5% Zacks
24-Sep-14 04:07PMCASTLE BRANDS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitiv EDGAR Online
04-Sep-14 06:00AMCASTLE BRANDS INC Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
02-Sep-14 01:57PMIPOs and Transactions: August 25 - 29 PR Newswire
22-Aug-14 01:04PMCASTLE BRANDS INC Financials EDGAR Online Financials
21-Aug-14 10:00AMRum: The Spirit Of The Caribbean Accesswire
14-Aug-14 04:57PMCASTLE BRANDS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit EDGAR Online
14-Aug-14 04:43PMCASTLE BRANDS INC Files SEC form 10-Q, Quarterly Report EDGAR Online
Castle Brands Inc. develops, markets, imports, and sells beverage alcohol products primarily in the United States. Its beverage alcohol categories include rum, whiskey, liqueurs, vodka, tequila, and wine. The company offers its products under the Gosling's rum, Gosling's Stormy Ginger Beer, Gosling's Dark n Stormy ready-to-drink cocktail, Jefferson's, Jefferson's Reserve and Jefferson's Presidential Select bourbons, Jefferson's rye whiskey, Pallini liqueurs, Clontarf Irish whiskey, Knappogue Castle Whiskey, Brady's Irish cream, Boru vodka, Tierras tequila, Celtic Honey liqueur, Castello Mio sambucas, and Gozio amaretto brands through a network of wholesale distributors and state-operated agencies. Castle Brands Inc. is based in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Glover John SChief Operating OfficerApr 15Option Exercise0.3882,23731,250477,527Apr 17 08:24 AM
ANDREWS MARKDirectorApr 10Option Exercise0.38178,89867,9812,912,659Apr 14 08:31 AM
ANDREWS MARKDirectorApr 10Option Exercise0.38164,47462,500686,684Apr 14 08:31 AM
ANDREWS MARKDirectorMar 10Option Exercise0.38165,16862,7642,733,761Mar 12 04:45 PM
LAMPEN RICHARDPresident and CEOFeb 24Option Exercise0.301,059,740322,1611,881,720Feb 25 08:37 AM
TickerXENT [NASD]
CompanyIntersect ENT, Inc.
CountryUSA
IndustryMedical Appliances & Equipment
Market Cap455.01MEPS (ttm)-0.78
P/E-EPS this Y-12.30%
Forward P/E-EPS next Y49.50%
PEG-EPS past 5Y0.00%
P/S16.67EPS next 5Y-
P/B-EPS Q/Q13.60%
Dividend-Sales Q/Q120.50%
Insider Own5.60%Inst Own47.70%
Insider Trans-Inst Trans10.44%
Short Float0.10%Earnings-
Analyst Recom1.50Target Price20.00
Avg Volume150.84K52W Range12.02 - 19.01
24-Oct-14 08:30AMCan the Rally in Intersect ENT (XENT) Shares Continue? Zacks
23-Oct-14 06:00AMNorwest Venture Partners Expands Presence With New Investment Team Hire and Office in San Francisco Marketwired
21-Oct-14 04:15PMIntersect ENT to Announce Third Quarter Financial Results GlobeNewswire
21-Oct-14 06:47AMInspireMD, Inc. (NSPR) Surges: Stock Moves 12.4% Higher Zacks
08-Oct-14 05:06PMIntersect ENT Announces Publication of Positive Data From Three Studies of Company's Drug-Eluting Sinus Implants GlobeNewswire
01-Oct-14 04:37PMIntersect ENT Added to Russell 2000 Index GlobeNewswire
22-Sep-14 08:25AMPhoto Release -- Intersect ENT Announces Positive Data From Clinical Trial of New In-Office Implant for Recurrent Chronic Sinusitis GlobeNewswire
17-Sep-14 05:58PMIntersect ENT Enrolls First Patient in Clinical Study to Expand Access to PROPEL Treatment to Broader Patient Population GlobeNewswire
05-Sep-14 05:19PMINTERSECT ENT, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib EDGAR Online
04-Sep-14 05:13PMINTERSECT ENT, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
Intersect ENT, Inc., a commercial stage drug-device company, provides therapeutic solutions for patients with ear, nose, and throat conditions in the United States. It offers PROPEL and PROPEL mini drug-eluting implants for patients undergoing sinus surgery to treat chronic sinusitis. The company was formerly known as Sinexus, Inc. and changed its name to Intersect ENT, Inc. in November, 2009. Intersect ENT, Inc. was founded in 2003 and is headquartered in Menlo Park, California.
1 2 3 4 5 6 ... 10 ... 13 next